Throughout the entire product life cycle, Dorsey’s life sciences and pharmaceutical patent group assists clients in all aspects of biotechnology and drug discovery. Our technical capabilities range from small molecule to biologics, as well as agribusiness, chemical patents, and other industries that increasingly use life sciences and molecular technologies. Many of our lawyers hold Ph.D.’s and master’s degrees in fields including molecular biology, biophysics and biophysical chemistry. Several of our patent attorneys were previously patent examiners at the United States Patent and Trademark Office.
We approach intellectual property as a part of a larger business strategy. We work with clients from the earliest stages of their technology development, and design patent portfolios to serve their business needs. We are often called on to perform legal analyses, draft opinions, and provide freedom to practice clearances. By staying attuned to legal developments, we help our clients navigate changes in the intellectual property landscape, and remain at the forefront of the life science and pharmaceutical industries.
We advise our clients on complex corporate, licensing, and patent enforcement issues as they arise. Our experience representing both investors and companies in intellectual property due diligence allows us to seamlessly work with Dorsey’s corporate practice to maximize patent portfolios in transactions. Dorsey’s biotechnology and pharmaceutical patent group also works closely with the firm’s general litigation attorneys to enforce. We also counsel life science and pharmaceutical companies in the regulatory, tax, and product liability areas. Recognition
Ranked as a "Band 2" firm in intellectual property by the UK's Chambers and Partners, “This well-balanced group of IP attorneys is experienced and knowledgeable in a number of fields and has, in the past year, advised many high-profile companies on complex patent disputes. It has expertise in biotechnology, chemicals, and mechanical and medical devices, among other areas.”